IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone
- PMID: 20008288
- DOI: 10.4049/jimmunol.0902717
IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone
Abstract
Buruli ulcer, caused by Mycobacterium ulcerans infections, is a necrotizing skin disease whose pathogenesis is associated with the exotoxin mycolactone. Despite the relevance of this emergent disease, little is known on the immune response against the pathogen. Following the recent demonstration of an intramacrophage growth phase for M. ulcerans, we investigated the biological relevance of IFN-gamma and the antimycobacterial mechanisms activated by this cytokine in M. ulcerans-infected macrophages. Three M. ulcerans strains were tested: 5114 (mutant mycolactone-negative, avirulent strain); 94-1327 (intermediate virulence); and 98-912 (high virulence). We show in this study that IFN-gamma is expressed in mouse-infected tissues and that IFN-gamma-deficient mice display increased susceptibility to infection with strains 5114 and, to a lesser extent, 94-1327, but not with the highly virulent strain. Accordingly, IFN-gamma-activated cultured macrophages controlled the proliferation of the avirulent and the intermediate virulent strains. Addition of mycolactone purified from strain 98-912 to cultures of IFN-gamma-activated macrophages infected with the mycolactone-negative strain led to a dose-dependent inhibition of the IFN-gamma-induced protective mechanisms, involving phagosome maturation/acidification and increased NO production, therefore resulting in increased bacterial burdens. Our findings suggest that the protection mediated by IFN-gamma in M. ulcerans-infected macrophages is impaired by the local buildup of mycolactone.
Similar articles
-
Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.Cell Microbiol. 2005 Sep;7(9):1295-304. doi: 10.1111/j.1462-5822.2005.00557.x. Cell Microbiol. 2005. PMID: 16098217
-
Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection.Infect Immun. 2007 Aug;75(8):3979-88. doi: 10.1128/IAI.00290-07. Epub 2007 May 21. Infect Immun. 2007. PMID: 17517872 Free PMC article.
-
Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin.Cell Microbiol. 2005 Aug;7(8):1187-96. doi: 10.1111/j.1462-5822.2005.00546.x. Cell Microbiol. 2005. PMID: 16008585
-
Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.Dermatol Clin. 2011 Jan;29(1):1-8. doi: 10.1016/j.det.2010.09.006. Dermatol Clin. 2011. PMID: 21095521 Review.
-
Buruli ulcer (Mycobacterium ulcerans infection).Trans R Soc Trop Med Hyg. 2008 Oct;102(10):969-78. doi: 10.1016/j.trstmh.2008.06.006. Epub 2008 Jul 26. Trans R Soc Trop Med Hyg. 2008. PMID: 18657836 Review.
Cited by
-
Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.J Exp Med. 2010 Aug 2;207(8):1609-16. doi: 10.1084/jem.20100265. Epub 2010 Jul 12. J Exp Med. 2010. PMID: 20624887 Free PMC article.
-
Individual and clinical variables associated with the risk of Buruli ulcer acquisition: A systematic review and meta-analysis.PLoS Negl Trop Dis. 2020 Apr 8;14(4):e0008161. doi: 10.1371/journal.pntd.0008161. eCollection 2020 Apr. PLoS Negl Trop Dis. 2020. PMID: 32267838 Free PMC article.
-
Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.PLoS One. 2012;7(3):e33406. doi: 10.1371/journal.pone.0033406. Epub 2012 Mar 8. PLoS One. 2012. PMID: 22413022 Free PMC article.
-
Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model.Infect Immun. 2020 Feb 20;88(3):e00753-19. doi: 10.1128/IAI.00753-19. Print 2020 Feb 20. Infect Immun. 2020. PMID: 31818964 Free PMC article.
-
Incidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulcerans infections.BMC Infect Dis. 2013 Sep 5;13:416. doi: 10.1186/1471-2334-13-416. BMC Infect Dis. 2013. PMID: 24007371 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases